COVID-19 and Headache: The New York Experience
AHSAM 2020 - Oral session
Published on July 17, 2020
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the AHSAM 2020 Virtual Annual Scientific Meeting and presented by:
Matthew S. Robbins, MD, FAHS
Associate Professor of Neurology, Neurology Residency Program Director
Weill Cornell Medicine
New York, New York
The content is produced by Infomedica, the official reporting partner of ASHAM 2020 Virtual Annual Scientific Meeting. The summary text was drafted by Goldcrest Medical Writing, reviewed by Marco Vercellino, MD, an independent external expert, and approved by Jessica Ailani, MD, FAHS and Mark J. Burish, MD, PhD, the scientific editors of the program.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
References
1. Parag Goyal, Justin J. Choi, Laura C. Pinheiro, et al. Clinical Characteristics of Covid-19 in New York City. N Engl J Med 2020;382:2372-2374.
2. David A. Berlin, Roy M. Gulick and Fernando J. Martinez. Severe COVID-19. N Engl J Med 2020; DOI: 10.1056/NEJMcp2009575.
